1. Home
  2. AWRE vs ADVM Comparison

AWRE vs ADVM Comparison

Compare AWRE & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AWRE
  • ADVM
  • Stock Information
  • Founded
  • AWRE 1986
  • ADVM 2006
  • Country
  • AWRE United States
  • ADVM United States
  • Employees
  • AWRE N/A
  • ADVM N/A
  • Industry
  • AWRE Computer Software: Prepackaged Software
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AWRE Technology
  • ADVM Health Care
  • Exchange
  • AWRE Nasdaq
  • ADVM Nasdaq
  • Market Cap
  • AWRE 50.3M
  • ADVM 49.9M
  • IPO Year
  • AWRE 1996
  • ADVM 2014
  • Fundamental
  • Price
  • AWRE $2.44
  • ADVM $2.91
  • Analyst Decision
  • AWRE
  • ADVM Strong Buy
  • Analyst Count
  • AWRE 0
  • ADVM 4
  • Target Price
  • AWRE N/A
  • ADVM $19.75
  • AVG Volume (30 Days)
  • AWRE 45.1K
  • ADVM 111.1K
  • Earning Date
  • AWRE 07-30-2025
  • ADVM 08-12-2025
  • Dividend Yield
  • AWRE N/A
  • ADVM N/A
  • EPS Growth
  • AWRE N/A
  • ADVM N/A
  • EPS
  • AWRE N/A
  • ADVM N/A
  • Revenue
  • AWRE $16,146,999.00
  • ADVM $1,000,000.00
  • Revenue This Year
  • AWRE N/A
  • ADVM N/A
  • Revenue Next Year
  • AWRE N/A
  • ADVM $18.82
  • P/E Ratio
  • AWRE N/A
  • ADVM N/A
  • Revenue Growth
  • AWRE N/A
  • ADVM N/A
  • 52 Week Low
  • AWRE $1.35
  • ADVM $1.78
  • 52 Week High
  • AWRE $2.68
  • ADVM $8.56
  • Technical
  • Relative Strength Index (RSI)
  • AWRE 60.96
  • ADVM 63.23
  • Support Level
  • AWRE $2.29
  • ADVM $2.20
  • Resistance Level
  • AWRE $2.52
  • ADVM $2.57
  • Average True Range (ATR)
  • AWRE 0.17
  • ADVM 0.20
  • MACD
  • AWRE 0.00
  • ADVM 0.05
  • Stochastic Oscillator
  • AWRE 82.50
  • ADVM 97.13

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

Share on Social Networks: